BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 324 filers reported holding BIONTECH SE in Q4 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $22,099 | -12.9% | 275 | 0.0% | 0.00% | – |
Q1 2024 | $25,369 | -12.6% | 275 | 0.0% | 0.00% | – |
Q4 2023 | $29,024 | -67.6% | 275 | -66.7% | 0.00% | -100.0% |
Q3 2023 | $89,628 | +0.7% | 825 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $89,042 | -20.0% | 825 | -7.7% | 0.00% | -50.0% |
Q1 2023 | $111,366 | -27.2% | 894 | -12.3% | 0.00% | -33.3% |
Q4 2022 | $153,074 | +11.7% | 1,019 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $137,000 | -11.6% | 1,019 | -1.8% | 0.00% | 0.0% |
Q2 2022 | $155,000 | -53.2% | 1,038 | -46.4% | 0.00% | -40.0% |
Q1 2022 | $331,000 | -33.8% | 1,938 | 0.0% | 0.01% | -37.5% |
Q4 2021 | $500,000 | -2.0% | 1,938 | +3.7% | 0.01% | -11.1% |
Q3 2021 | $510,000 | +9.4% | 1,869 | -10.1% | 0.01% | +12.5% |
Q2 2021 | $466,000 | -99.9% | 2,080 | -59.1% | 0.01% | +60.0% |
Q1 2021 | $554,686,000 | +803792.8% | 5,080 | +497.6% | 0.01% | +400.0% |
Q4 2020 | $69,000 | +590.0% | 850 | +466.7% | 0.00% | – |
Q3 2020 | $10,000 | +42.9% | 150 | +50.0% | 0.00% | – |
Q2 2020 | $7,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 148,674 | $11,947,443 | 19.99% |
Quinn Opportunity Partners LLC | 683,287 | $54,908,943 | 6.24% |
Krensavage Asset Management, LLC | 132,293 | $10,631 | 4.88% |
Crocodile Capital Partners GmbH | 29,586 | $2,377,531 | 3.78% |
ALTRINSIC GLOBAL ADVISORS LLC | 676,219 | $54,340,958 | 2.42% |
FLOSSBACH VON STORCH AG | 4,379,483 | $351,935,254 | 1.48% |
Systrade AG | 10,000 | $803,600 | 1.38% |
HARDING LOEVNER LP | 2,926,761 | $235,224,417 | 1.30% |
CenterBook Partners LP | 206,234 | $16,572,964 | 1.03% |
SECTORAL ASSET MANAGEMENT INC | 27,265 | $2,191,015 | 0.89% |